PharmaMar. Driven by People, Powered by the Sea.

Our North Star is to improve the healthcare outcomes of patients afflicted by serious diseases with our innovative medicines.

What is PharmaMar?

What is PharmaMar?

What makes the sea so powerful?

The force behind the waves?
The wind blowing across it.
Its vastness perhaps…
Or is it something deeper?
Something that cannot be seen from above.
But only by diving in.
By exploring the life teeming below the surface.

What makes the sea so powerful?

A UNIQUE COMPANY​

Patients Are Our North Star​

PharmaMar is a unique company as a pioneer of marine based novel cancer medicines for over thirty years. We are inspired by the sea, driven by science, and motivated by patients with serious diseases to improve their lives by delivering novel medicines to them. We intend to continue to be the world leader in marine medicinal discovery, development and innovation.

Cancer is the second leading cause of death in the world

Cancer is the second leading cause of death in the world, after cardiovascular disease. Far from being optimistic, international agencies warn that the figures are increasing. In fact, according to projections of the World Health Organization, nearly 30 million new cases worldwide will be diagnosed in 2040, up 63.7% from today.

PharmaMar is one of the ten Spanish pharmaceutical companies that the Ministry of Industry has recently qualified as excellent, taking into account industrial, economic, research & development and innovation aspects.

A PASSIONATE MULTIDISCIPLINARY TEAM

Driven by people, powered by science

We are a multi-disciplinary R&D team of biologists, chemists, clinicians, engineers, computer technicians, lab professionals, biostatisticians, supported by so many more, all working tirelessly towards one goal; to improve the healthcare outcomes of people afflicted with serious diseases. One of our values is respect; to treat with respect, integrity and dignity all of our stakeholders, the central one of which is these people afflicted with serious diseases.

Meet the team →
Careers →

"PharmaMar was the first company in the world to market a marine-derived anticancer drug. We have the largest library of marine organisms with over 250,000 samples."

Luis Mora

Managing Director

SINCE 1986

Three decades of discoveries​

We are inspired by the sea, driven by science, and motivated by patients with serious diseases to improve their lives by delivering novel medicines to them. We intend to continue to be the world leader in marine medicinal discovery, development and innovation.

Our Marketed Drugs

For over 30 years from its start in 1986, PharmaMar reinvested revenues or partnership income into R&D and building out the team.

TRABECTEDIN

Yondelis®

Treatment of patients with soft-tissue sarcoma and ovarian cancer.

LURBINECTEDIN

Zepzelca®

Treatment of patients with small cell lung cancer.

PLITIDEPSIN

Aplidin®

Treatment of multiple myeloma.

Our international presence

We have 18 partners that cover over 100 countries for our three commercial drugs.

PharmaMar is headquartered in Madrid, Spain and covers eight major European countries from its subsidiaries in Germany, France, Italy, Belgium, Austria, Switzerland and The United States. In addition, we have local distributors already in place in the remaining parts of Europe.

How to get here?

Avda. De los Reyes, 1
28770 - Colmenar Viejo, Madrid, Spain
Coordinates: 40.6569210234968, -3.7539595609498835
How to get here?

0.3639 seconds.